Durgical
EN
Open the app

Insulin: basal, mealtime and correction, in principle

  • Follow-up and treatment

Insulin therapy copies what a healthy pancreas does: a steady background trickle all day, plus a burst at each meal. Missing either half causes trouble.

Updated

See it in 3D: Pancreas

What it is

A healthy pancreas releases insulin in two ways: a low, steady basal secretion that holds liver glucose output in check between meals and overnight, and quick prandial bursts that handle the glucose of each meal. Insulin therapy imitates this with basal insulin (long-acting analogues such as glargine, detemir and degludec, or intermediate NPH), mealtime insulin (rapid-acting analogues such as lispro, aspart and glulisine, or short-acting regular human insulin) and correction insulin, extra rapid insulin to bring down a high reading. People with type 1 diabetes make almost no insulin and need both basal and mealtime insulin from diagnosis, by injection or pump. In type 2 diabetes insulin is added when other drugs cannot reach the target, when glucose is very high or catabolic symptoms appear, during pregnancy, acute illness or hospital stays, and when kidney or liver disease rule out other drugs; it usually starts with basal insulin.

What to know

  • Basal insulin controls fasting and overnight glucose; mealtime insulin controls the rise after eating; correction insulin fixes a high reading but does not replace either.
  • Type 1 diabetes always needs basal insulin, even when not eating: without it, fat breakdown and ketoacidosis begin within hours.
  • Long-acting analogues have a flatter profile than NPH and cause less nocturnal hypoglycaemia; NPH is cheaper and peaks some hours after injection.
  • Rapid-acting analogues are given just before meals; regular human insulin acts more slowly and is given earlier before eating.
  • Premixed insulins combine an intermediate and a rapid or short component: simpler, but less flexible and with more hypoglycaemia if meals are irregular.
  • In type 2 diabetes, a GLP-1 receptor agonist is often tried before insulin, or combined with basal insulin, to limit weight gain and hypoglycaemia.
  • Overbasalisation: when basal insulin keeps being raised to fix high post-meal readings, the patient gets night or fasting lows while the day stays high; meal coverage is what is missing.
  • Injection sites are rotated; repeated injection into one spot causes lipohypertrophy, a rubbery lump where insulin absorbs erratically.
  • Hypoglycaemia is the main hazard: anyone on insulin needs to recognise and treat it and, if at risk of severe episodes, have glucagon at home.
  • Insulin requirement falls with kidney failure, weight loss, exercise and alcohol, and rises with infection, glucocorticoids and puberty.

The three jobs of insulin therapy

ComponentWhat it copiesExamplesWhat it fixesTypical problem
BasalSteady background secretionGlargine, detemir, degludec; NPHFasting and overnight glucoseToo much: night and fasting lows
Mealtime (bolus)Burst after each mealLispro, aspart, glulisine; regularRise after eatingMismatch with food: lows or highs after meals
CorrectionResponse to an unexpected highRapid-acting or regular insulinA high reading at that momentUsed alone it only chases highs
PremixedBasal and meal cover in one injectionNPH with regular, or analogue mixesFewer injectionsRigid: needs regular meals

In the clinic

  • A patient with type 1 diabetes who is vomiting and not eating still needs basal insulin and needs blood ketones checked: stopping insulin «because I am not eating» is a classic route to ketoacidosis.
  • High fasting glucose despite basal insulin in a person who eats late at night may be a meal problem, not a basal one: look at the pattern before changing anything.
  • Unexplained erratic readings: check the injection sites for lipohypertrophy and the technique, storage and expiry of the insulin.
  • Rising hypoglycaemia on a stable regimen suggests falling kidney function, weight loss, adrenal insufficiency or coeliac disease in type 1.

Next step / Initial management

  • Before starting insulin: teach injection technique, site rotation, storage, glucose monitoring, and recognition and treatment of hypoglycaemia.
  • Monitor with capillary glucose or continuous glucose monitoring; review patterns (fasting, before and after meals, overnight) rather than single values.
  • Every person on insulin with risk of severe hypoglycaemia should have glucagon and someone trained to give it.
  • Doses and adjustments follow the treating team's written plan; these pages teach the principle only.
  • Refer to endocrinology all type 1 diabetes, type 2 diabetes with recurrent hypoglycaemia or unexplained erratic control, and pregnancy on insulin.

Common traps

  • Type 1 can skip insulin on a day without food: basal insulin is still needed because the liver keeps producing glucose and, without insulin, fat breakdown makes ketones.
  • Sliding-scale correction alone is enough insulin: it only reacts after glucose is already high and gives no background cover, so control swings and ketosis can develop in type 1.
  • Higher fasting glucose always means more basal insulin: night lows followed by rebound highs, late meals or missed meal cover can give the same picture.
  • Insulin is the last resort in type 2 diabetes: it is started early when glucose is very high or there is weight loss and ketosis, because glucose toxicity itself impairs beta cells.
  • Every insulin acts the same way: onset, peak and duration differ widely, which is why NPH peaks cause lows hours after the injection and rapid analogues work best just before eating.

Test yourself

Think of the answer, then tap the question to see it.

A 17-year-old with type 1 diabetes has gastroenteritis and skipped all insulin because he cannot eat. Why is he at risk?

Without basal insulin the liver keeps releasing glucose and fat breakdown makes ketones: he can develop ketoacidosis. Basal insulin continues, with ketone checks.

A man on basal insulin only has fasting readings that are low but afternoon readings that are high. What is wrong?

Overbasalisation: basal insulin is being used to cover meals. The meal rise needs mealtime cover or another drug, not more basal insulin.

A woman's glucose has become unpredictable and she always injects in the same spot on her abdomen. What do you look for?

Lipohypertrophy: a rubbery swelling at the site where insulin is absorbed erratically. Rotating sites restores predictable absorption.

Why does NPH cause more nocturnal hypoglycaemia than a long-acting analogue?

NPH has a peak several hours after injection; given in the evening, that peak can fall in the night, whereas long-acting analogues are flatter.

Add to my cards (4)

Elsewhere in DurgiPedia

Connections

← All of endocrinology

Educational content; it does not replace a medical assessment and is not a clinical instruction. For confusion, persistent vomiting with diabetes, fainting or very low blood pressure in someone who takes or has stopped glucocorticoids, go to an emergency department at once.

Sources: Insulin (StatPearls (NCBI Bookshelf), 2023); NPH Insulin (StatPearls (NCBI Bookshelf), 2023); Glargine Insulin (StatPearls (NCBI Bookshelf), 2022); Insulin Lispro (StatPearls (NCBI Bookshelf), 2024); Type 1 Diabetes (StatPearls (NCBI Bookshelf), 2024); Hypoglycemia (StatPearls (NCBI Bookshelf), 2022).

Spotted a mistake?We are always improving for the community. Tell us what is wrong and our team will review it.Report a mistake

Representative model, for educational purposes only.